(AIR) Airbus SE - Overview
Stock: Commercial Aircraft, Helicopters, Military Aircraft, Satellites, Launchers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.25% |
| Yield on Cost 5y | 3.42% |
| Yield CAGR 5y | 25.99% |
| Payout Consistency | 74.8% |
| Payout Ratio | 31.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.8% |
| Relative Tail Risk | -5.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | 10.34 |
| Character TTM | |
|---|---|
| Beta | 0.225 |
| Beta Downside | 0.418 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.08% |
| CAGR/Max DD | 0.73 |
Description: AIR Airbus SE January 27, 2026
Airbus SE (ticker AIR) operates through three core divisions: the Airbus commercial-aircraft business, Airbus Helicopters, and Airbus Defence and Space. The commercial segment designs, builds, and sells passenger, freighter, and regional turboprop aircraft as well as components and conversion services. Airbus Helicopters supplies civil and military rotorcraft and related support, while the Defence and Space arm delivers manned and unmanned military systems, satellite and launch services, and cyber-security solutions.
According to the 2023 annual report, Airbus generated €78.9 billion in total revenue, with a record commercial-aircraft backlog of €415 billion and 661 aircraft delivered in FY 2023. The Helicopters division posted 212 deliveries and €2.2 billion in revenue, and Defence & Space contributed €7.5 billion, reflecting a 12 % year-over-year increase driven by higher defense spending in Europe and the U.S. R&D intensity remained around 7 % of revenue (≈ €5.9 billion), underscoring continued investment in next-generation technologies.
Key macro drivers include the post-pandemic rebound in global passenger traffic (IATA forecasts 2024 passenger growth of ~4 %), sustained government defense budgets (average NATO member increase of 3 % YoY), and expanding commercial-space demand (global satellite-launch market projected to grow > 10 % CAGR through 2028). For a deeper quantitative view of Airbus’s valuation metrics, you might find ValueRay’s dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 5.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.38 > 1.0 |
| NWC/Revenue: 11.74% < 20% (prev 12.41%; Δ -0.67% < -1%) |
| CFO/TA 0.06 > 3% & CFO 7.43b > Net Income 5.07b |
| Net Debt (5.18b) to EBITDA (10.29b): 0.50 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (789.4m) vs 12m ago -0.42% < -2% |
| Gross Margin: 15.54% > 18% (prev 0.15%; Δ 1539 % > 0.5%) |
| Asset Turnover: 56.87% > 50% (prev 54.33%; Δ 2.54% > 0%) |
| Interest Coverage Ratio: 8.97 > 6 (EBITDA TTM 10.29b / Interest Expense TTM 824.0m) |
Altman Z'' 1.51
| A: 0.07 (Total Current Assets 69.41b - Total Current Liabilities 60.94b) / Total Assets 129.67b |
| B: 0.15 (Retained Earnings 19.32b / Total Assets 129.67b) |
| C: 0.06 (EBIT TTM 7.39b / Avg Total Assets 126.86b) |
| D: 0.20 (Book Value of Equity 20.12b / Total Liabilities 102.33b) |
| Altman-Z'' Score: 1.51 = BB |
Beneish M -2.78
| DSRI: 1.32 (Receivables 10.25b/7.27b, Revenue 72.15b/67.40b) |
| GMI: 0.97 (GM 15.54% / 15.01%) |
| AQI: 0.97 (AQ_t 0.31 / AQ_t-1 0.32) |
| SGI: 1.07 (Revenue 72.15b / 67.40b) |
| TATA: -0.02 (NI 5.07b - CFO 7.43b) / TA 129.67b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
What is the price of AIR shares?
Over the past week, the price has changed by -1.09%, over one month by -8.64%, over three months by -8.32% and over the past year by +16.56%.
Is AIR a buy, sell or hold?
What are the forecasts/targets for the AIR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 226 | 18.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 227.1 | 18.7% |
AIR Fundamental Data Overview February 03, 2026
P/E Trailing = 30.2187
P/E Forward = 24.3309
P/S = 2.1159
P/B = 6.4865
P/EG = 1.1466
Revenue TTM = 72.15b EUR
EBIT TTM = 7.39b EUR
EBITDA TTM = 10.29b EUR
Long Term Debt = 7.17b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.37b EUR (from shortTermDebt, last quarter)
Debt = 13.52b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.18b EUR (from netDebt column, last quarter)
Enterprise Value = 154.93b EUR (152.67b + Debt 13.52b - CCE 11.26b)
Interest Coverage Ratio = 8.97 (Ebit TTM 7.39b / Interest Expense TTM 824.0m)
EV/FCF = 43.30x (Enterprise Value 154.93b / FCF TTM 3.58b)
FCF Yield = 2.31% (FCF TTM 3.58b / Enterprise Value 154.93b)
FCF Margin = 4.96% (FCF TTM 3.58b / Revenue TTM 72.15b)
Net Margin = 7.02% (Net Income TTM 5.07b / Revenue TTM 72.15b)
Gross Margin = 15.54% ((Revenue TTM 72.15b - Cost of Revenue TTM 60.94b) / Revenue TTM)
Gross Margin QoQ = 16.42% (prev 14.76%)
Tobins Q-Ratio = 1.19 (Enterprise Value 154.93b / Total Assets 129.67b)
Interest Expense / Debt = 1.34% (Interest Expense 181.0m / Debt 13.52b)
Taxrate = 33.52% (547.0m / 1.63b)
NOPAT = 4.91b (EBIT 7.39b * (1 - 33.52%))
Current Ratio = 1.14 (Total Current Assets 69.41b / Total Current Liabilities 60.94b)
Debt / Equity = 0.50 (Debt 13.52b / totalStockholderEquity, last quarter 27.25b)
Debt / EBITDA = 0.50 (Net Debt 5.18b / EBITDA 10.29b)
Debt / FCF = 1.45 (Net Debt 5.18b / FCF TTM 3.58b)
Total Stockholder Equity = 22.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.99% (Net Income 5.07b / Total Assets 129.67b)
RoE = 22.04% (Net Income TTM 5.07b / Total Stockholder Equity 22.98b)
RoCE = 24.51% (EBIT 7.39b / Capital Employed (Equity 22.98b + L.T.Debt 7.17b))
RoIC = 15.85% (NOPAT 4.91b / Invested Capital 30.99b)
WACC = 6.26% (E(152.67b)/V(166.19b) * Re(6.74%) + D(13.52b)/V(166.19b) * Rd(1.34%) * (1-Tc(0.34)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 87.14% ; FCFF base≈2.83b ; Y1≈3.49b ; Y5≈5.95b
Fair Price DCF = 188.8 (EV 154.18b - Net Debt 5.18b = Equity 149.00b / Shares 789.4m; r=6.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -7.94 | EPS CAGR: 7.66% | SUE: 0.71 | # QB: 0
Revenue Correlation: 32.15 | Revenue CAGR: 1.28% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.76 | Chg30d=-0.020 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=7.78 | Chg30d=-0.100 | Revisions Net=-10 | Growth EPS=+21.8% | Growth Revenue=+12.5%